Top Markets
Coin of the day
Sanofi Sanofi

Sanofi

SNY
Rang in aandelen #179
Sanofi, together with its subsidiaries, engages in the research, development,... Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Aandeelprijs
$44.60
Marktkapitalisatie
$108.62B
Verandering (1 dag)
-1.63%
Verandering (1 jaar)
-21.62%
Land
FR
Handel Sanofi (SNY)

Categorie

Operationele marge voor Sanofi (SNY)
Operationele marge op March 2026 TTM: 25.39%
Volgens de meest recente financiële rapporten en aandelenkoers van Sanofi is de huidige operationele marge (TTM) 25.39%. Eind 2024 had het bedrijf een operationele marge van 21.47%.
Geschiedenis van de operationele marge van Sanofi van 2000 tot 2026
Operationele marge aan het einde van elk jaar
Jaar Operationele Marge Wijzigen
2026 (TTM) 25.39% -22.28%
2025 32.67% 52.17%
2024 21.47% 25.48%
2023 17.11% -53.76%
2022 37.00% 78.40%
2021 20.74% -4.11%
2020 21.63% 5.77%
2019 20.45% -41.30%
2018 34.84% 5.10%
2017 33.15% -6.80%
2016 35.57% -2.44%
2015 36.46% -7.58%
2014 39.45% -5.12%
2013 41.58% -4.79%
2012 43.67% 167.09%
2011 16.35% -12.14%
2010 18.61% -10.10%
2009 20.70% -38.90%
2008 33.88% 67.39%
2007 20.24% 4.17%
2006 19.43% -25.64%
2005 26.13% -1,593.14%
2004 -1.75% -104.58%
2003 38.21% 8.89%
2002 35.09% 8.10%
2001 32.46% 22.72%
2000 26.45% 0.00%
Operationele marge van vergelijkbare bedrijven of concurrenten
Bedrijf Operationele Marge Verschil in operationele marge Land
45.56% -98.21%
US
23.28% -99.08%
GB
27.17% -98.93%
US
26.72% -98.95%
US
31.24% -98.77%
CH
Wat is de Operationele marge van een bedrijf?
De Operationele marge is een belangrijke indicator om de winstgevendheid van een bedrijf te beoordelen. Hogere operationele marges zijn over het algemeen beter omdat ze aangeven dat een bedrijf zijn producten of diensten veel duurder kan verkopen dan de productiekosten. De Operationele marge wordt berekend door de winst van een bedrijf te delen door de omzet.